July options expiration is tomorrow … and it’s time to take early action on two of your trades.
Specifically, I recommend you …
Buy to close the July Energy Select Sector SPDR Fund (NYSE:...
By Jon D. Markman On July 15, 202106:28 AM Eastern
* * *
Publication Update: Hey, I’m back from vacation. Played about 15 rounds of golf in two and a half weeks, hiked with my wife, sister, and daughter, took the dogs on long walks in the...
By Kelly Green On July 15, 202106:00 AM Eastern
Have you ever wondered who the largest money manager in the world is? Spoiler: It’s BlackRock, Inc. (NYSE: BLK). The company now has approximately $9.5 trillion under management.
For the first...
By Kenny Polcari On July 15, 202112:00 AM Eastern
It's the crossover event of the century! Kenny teams up with fellow wealth management extraordinaire Joe Saul-Sehy, the host of the smash hit podcast STACKING BENJAMINS and the author of the...
By Alex Benfield On July 14, 202103:00 PM Eastern
• Bitcoin (BTC, Tech/Adoption Grade “A-”) holds support once again, perhaps suggesting that holders no longer have an appetite for selling.
• Ethereum (ETH, Tech/Adoption Grade “A”) attempted...
By Sean Brodrick On July 14, 202111:24 AM Eastern
I have a couple of trades for you today, plus the latest on your portfolio.
There’s a lot to cover, but let’s ring the cash register first. Sturm, Ruger & Company, Inc. (NYSE: RGR) has lost some...
By Mike Larson On July 14, 202106:00 AM Eastern
The “Money Flood” is a massive wave of cheap liquidity and abundant stimulus, the likes of which we’ve never seen.
I’ve said over and over that it’s pointless to fight it. Your best bet is to go...
By The Weiss Crypto Team On July 13, 202104:00 PM Eastern
Inflation is a hot topic at the moment, with the Federal Reserve still peddling its line that any uptick in inflation is just transitory. And Wall Street is buying it hook, line and sinker.
...
By Jon D. Markman On July 13, 202106:58 AM Eastern
Biotechnology is near a watershed moment. For the first time, gene editing has been shown to work effectively in humans.
According to trial data released in June by Intellia (Nasdaq: NTLA) and...
By David Dittman On July 13, 202106:00 AM Eastern
It can be hard for many (and impossible for others) to discern a viable trend amid the kind of chop (and the noise) we’ve experienced lately in equity markets.
For some, like my colleague Sean...